Myristoylated alanine-rich C-kinase substrate (MARCKS) protein regulation of human neutrophil migration

Neutrophil migration into infected tissues is essential for host defense, but products of activated neutrophils can be quite damaging to host cells. Neutrophil influx into the lung and airways and resultant inflammation characterizes diseases such as chronic obstructive pulmonary disease, bronchiect...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory cell and molecular biology Vol. 42; no. 5; pp. 586 - 594
Main Authors Eckert, Rachael E, Neuder, Laura E, Park, Joungjoa, Adler, Kenneth B, Jones, Samuel L
Format Journal Article
LanguageEnglish
Published United States American Thoracic Society 01.05.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Neutrophil migration into infected tissues is essential for host defense, but products of activated neutrophils can be quite damaging to host cells. Neutrophil influx into the lung and airways and resultant inflammation characterizes diseases such as chronic obstructive pulmonary disease, bronchiectasis, and cystic fibrosis. To migrate, neutrophils must reorganize the actin cytoskeleton to establish a leading edge pseudopod and a trailing edge uropod. The actin-binding protein myristoylated alanine-rich C-kinase substrate (MARCKS) has been shown to bind and cross-link actin in a variety of cell types and to co-localize with F-actin in the leading edge lamellipodium of migrating fibroblasts. The hypothesis that MARCKS has a role in the regulation of neutrophil migration was tested using a cell-permeant peptide derived from the MARCKS myristoylated aminoterminus (MANS peptide). Treatment of isolated human neutrophils with MANS significantly inhibited both their migration and beta2 integrin-dependent adhesion in response to N-formyl-methionyl-leucyl-phenylalanine (fMLF), IL-8, or leukotriene (LT)B(4). The IC(50) for fMLF-induced migration and adhesion was 17.1 microM and 12.5 microM, respectively. MANS significantly reduced the F-actin content in neutrophils 30 seconds after fMLF stimulation, although the peptide did not alter the ability of cells to polarize or spread. MANS did not alter fMLF-induced increases in surface beta2 integrin expression. These results suggest that MARCKS, via its myristoylated aminoterminus, is a key regulator of neutrophil migration and adhesion.
Bibliography:This work was supported by Grant # R37 HL36982 from the National Institutes of Health and by a Pilot Grant from the NCSU Center for Comparative Medicine and Translational Research.
Originally Published in Press as DOI: 10.1165/rcmb.2008-0394OC on July 2, 2009
Conflict of Interest Statement: K.B.A. serves on the scientific advisory board of Sepracor, Inc. and received $5,000 for this service in 2005, $5,000 in 2006, and $5,000 in 2007, and served as a consultant to Immunogen and received $1,500 in 2004. He received $68,000 in 2004–2005 as a research grant from AstraZeneca and approximately $140,000 in research grants from Sepracor since 2002. He holds 150,000 founders shares of a start-up biotech company, BioMarck, and serves as a scientific consultant and member of the scientific advisory board without monetary compensation. S.L.J. received $180 from Gerson Lehman Group for consultations in 2008 and 2007, and also received $31,000 from BioMarck Pharmaceuticals in 2006 as a research grant. None of the other authors has a financial relationship with a commercial entity that has an interest in the subject of this manuscript.
ISSN:1044-1549
1535-4989
DOI:10.1165/rcmb.2008-0394oc